1-3 of 3
Atsushi Irie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto, Satoru Senju, Yasuhiro Kuroda, Masatoshi Hirayama, Atsushi Irie, Kenta Kawahara, Junji Yatsuda, Akinobu Hamada, Hirofumi Jono, Koji Yoshida, Takuya Tsunoda, Hirotsugu Kohrogi, Yoshihiro Yoshitake, Yusuke Nakamura, Masanori Shinohara, Yasuharu Nishimura
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (16): 4508–4520.
https://doi.org/10.1158/1078-0432.CCR-13-0197
Published: 13 August 2013
View article titled, Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4<sup>+</sup> and CD8<sup>+</sup> T-cell Epitopes: KIF20A-Specific CD4<sup>+</sup> T-cell Immunity in Patients with Malignant Tumor
Open the PDF for Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4<sup>+</sup> and CD8<sup>+</sup> T-cell Epitopes: KIF20A-Specific CD4<sup>+</sup> T-cell Immunity in Patients with Malignant Tumor in another window
Includes: Supplementary data
Journal Articles

Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)

Hidetoshi Nitta, Yoshihiro Wada, Yoshiaki Kawano, Yoji Murakami, Atsushi Irie, Keisuke Taniguchi, Ken Kikuchi, Gen Yamada, Kentaro Suzuki, Jiro Honda, Masayo Wilson-Morifuji, Norie Araki, Masatoshi Eto, Hideo Baba, Takahisa Imamura
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2004–2013.
https://doi.org/10.1158/1078-0432.CCR-12-1204
Published: 15 April 2013
View article titled, Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
Open the PDF for Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88) in another window
Includes: Multimedia, Supplementary data
Journal Articles

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Katsunori Imai, Shinya Hirata, Atsushi Irie, Satoru Senju, Yoshiaki Ikuta, Kazunori Yokomine, Michiko Harao, Mitsuhiro Inoue, Takuya Tsunoda, Shuichi Nakatsuru, Hidewaki Nakagawa, Yusuke Nakamura, Hideo Baba, Yasuharu Nishimura
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6487–6495.
https://doi.org/10.1158/1078-0432.CCR-08-1086
Published: 16 October 2008
View article titled, Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers
Open the PDF for Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers in another window
Includes: Supplementary data